GrowthTurtle
Data Science PhD & IEEE Fellow, Ex-Two Sigma
FormFactor is expensive against its earnings, trading at about 38x when chip-equipment makers usually get 18x. Fair value sits at $60.06 to $76.44, or 18x next year's $3.79 EPS give or take 12%, so at $145.97 the price is about 91% above fair. The valuation also leans on the forecast, with forward EPS 177% above trailing. This is a levels-only read off reported earnings and revenue estimates, with no fundamental work. x.comÂ
FormFactor's 2030 target model implies either a still-high multiple in 2030 or disappointing share-price gains over the next few years. The model, cited via Citi and apparently management's own, targets $1.6B revenue, 55% gross margin and $5 EPS. The modeled TAM may prove higher, but a margin of safety means assuming today's high multiple won't stay as high. x.com x.com x.com x.comÂ
Accelerating earnings mean ASML is not expensive right now. It trades at 24x forward earnings and 19x forward EV/EBITDA. x.comÂ
FormFactor's rebounding free cash flow and operating margins suggest it is making the right moves in the tough, competitive chip-testing segment. Against ASML, the segment's beast, FormFactor has better growth and a 40% lower PEG. The chart is ready to move again, with a pattern target of 143 versus an all-time high around 160. x.com x.comÂ
Intel's high valuation is hard to justify while its foundry turnaround remains unproven. At about 59x forward earnings, nearly three times TSMC's 19x, Intel has slower projected revenue growth; its foundry lost $2.09 billion in Q2 2026, while TSMC's Q3 operating margin was 58.7%. A politician's stock purchase alone does not make Intel a buy. x.com x.comÂ
The Nasdaq 100 already effectively prices in a severe semiconductor recession. QQQ trades at about 20 times 2027 EPS versus a 10-year average forward P/E near 25; halving 2027 estimates for Nvidia, Broadcom, AMD, Micron, Lam Research and Applied Materials would lift that only to 24.5. If the market instead traded at 20 times in that scenario, downside would be about 20%. Capex seems unlikely to be cut materially unless growth at AI labs such as Anthropic decelerates dramatically. x.comÂ
FormFactor is breaking out on record fundamentals. It posted three straight revenue records, a run rate above $1B and gross margin above 50% for the first time, and the shares rose 15% on the week. x.comÂ
Amtech Systems' 131x trailing P/E hides an advanced-packaging turnaround. Its TrueFlat technology on Pyramax vacuum reflow platforms tackles substrate warpage in stacked dies and HBM, and these systems are over 30% of thermal segment revenue, heading past 40%. A semi-fabless shift under CEO Robert Daigle lifted gross margin to 47.7% on Q2 revenue up 31%, and its silicon carbide polishing consumables are rebounding. Institutions buying a $60M raise at $20.50 signal significant upside. x.comÂ
ASML's valuation does not make sense at 45-50x forward earnings unless estimates are too low by around 2x. It has always had pricing power but chosen not to exercise it; that may change, but if it does not, the multiple is hard to justify relative to other opportunities. x.com x.comÂ
FormFactor sits in test and packaging, the best corner of semiconductors this year, where much quiet money is being made in the layer that makes compute functional. It makes the probe cards that test chips and ranks first globally in test subsystems. Last quarter set a revenue record, up 32%, with gross margin up 510 basis points to 49% and EPS beating by 33%. DRAM probe card revenue hit a record on HBM, a product sold out through 2030. x.comÂ
Applied Materials' record revenue and Q4 guidance show strong AI equipment demand, and the median analyst target implies 42.9% upside over the next 12 months. x.comÂ
